Arrowhead Pharmaceuticals, Inc.
USD82.78
+2.28 (+2.83%)
CEO
Christopher R. Anzalone
IPO Date
1993-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$82.00
Prev. Close
$80.50
Day Low
$78.86
Day High
$84.06
52W Low
$14.30
52W High
$84.55
Market Cap
$11.66B
Volume
1.00M
| -3.9 |
| 30 Sept 2023 | FY | 94.8% | -85.3% | -75.7% | -26.8% | 1.41 | 3.98 | -14.0 |
| 30 Sept 2022 | FY | 95.7% | -72.4% | -44.2% | -25.4% | 0.20 | 2.92 | -19.8 |
| 30 Sept 2021 | FY | 0.0% | -101.9% | -34.5% | -19.8% | 0.06 | 2.62 | -46.0 |
| 30 Sept 2020 | FY | 0.0% | -96.1% | -18.3% | -16.2% | 0.05 | 7.92 | -51.3 |
| 30 Sept 2019 | FY | 0.0% | 40.3% | 27.8% | 19.4% | 0.00 | 2.73 | 38.9 |
| 30 Sept 2018 | FY | 0.0% | -337.3% | -56.8% | -48.8% | 0.02 | 6.37 | -29.5 |
| 30 Sept 2017 | FY | 0.0% | -109.5% | -42.2% | -33.1% | 0.03 | 3.63 | -9.2 |
| 30 Sept 2016 | FY | 0.0% | -51614.6% | -85.5% | -63.8% | 0.03 | 3.53 | -5.5 |
| 75.4 |
| 30 Sept 2025 | Q4 | 100.0% | -9.3% | -5.1% | -1.7% | 0.79 | 4.86 | -49.3 |
| 30 Jun 2025 | Q3 | 100.0% | -631.1% | -33.6% | -12.7% | 1.37 | 4.87 | -3.1 |
| 31 Mar 2025 | Q2 | 100.0% | 68.3% | 54.2% | 23.5% | 1.08 | 5.15 | 1.1 |
| 31 Dec 2024 | Q1 | 100.0% | -6923.4% | -329.1% | -17.1% | 16.58 | 6.09 | -3.4 |
| 30 Sept 2024 | Q4 | 0.0% | 0.0% | -92.0% | -15.0% | 4.59 | 6.74 | -3.5 |
| 30 Jun 2024 | Q3 | 0.0% | 0.0% | -51.7% | -19.3% | 1.37 | 4.65 | -4.7 |
| 31 Mar 2024 | Q2 | 0.0% | 0.0% | -25.9% | -13.1% | 0.83 | 8.31 | -6.9 |
| 31 Dec 2023 | Q1 | -20.1% | -3741.6% | -82.8% | -21.2% | 2.45 | 3.73 | -6.2 |